Skip to main content
. 2020 Sep;8(17):1100. doi: 10.21037/atm-20-3928

Figure 8.

Figure 8

Abdominal computed tomography (CT) imaging performed on February 25, 2020 showed that the metastatic lesions (as pointed by red arrows) in the liver had progressed significantly after the first cycle of pembrolizumab plus abraxane.